Patent · US Active

Enterprise market volatility predictions through synthetic DNA and mutant nucleotides

US11823066B2 · kind B2 · utility

0Cited by
5References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 28, 2021
Grant dateNov 21, 2023
Priority date
Expiry dateMay 28, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG06N3/09
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

Aspects of the disclosure relate to using synthetic DNA stranding and mutant nucleotide processes to conduct enterprise market volatility predictions. In some embodiments, a computing platform may receive market data from a plurality of lines of business across an enterprise, wherein the market data is received in a raw, uncompressed format. Thereafter, the computing platform may assimilate and preprocess the market data to output vectored market data. The computing platform may perform a synthetic DNA stranding process on the vectored market data to create one or more strands of synthetic DNA market data, and output the one or more strands of synthetic DNA market data to a synthetic DNA client server, wherein the one or more stands of synthetic DNA market data is configured for input in a market volatility prediction model.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.